Evidence map›Paper›PMID 36986311›Full record

ArticlePathogens (Basel, Switzerland)2023

Characterization of COVID-19 Hospitalized Patients in Three United States Electronic Health Record Databases.

Patrick Saunders-Hastings, Cindy Ke Zhou, Shayan Hobbi, Eva Boyd, Patricia Lloyd, Nader Alawar, Timothy Burrell, Jeff Beers, Tainya C Clarke, Aaron Z Hettinger and 2 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Patrick Saunders-HastingsGevity Consulting Inc., part of Accenture, Ottawa, ON K1P 1A4, Canada.
Cindy Ke ZhouCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Shayan HobbiIBM Consulting, Bethesda, MD 20814, USA.
Eva BoydGevity Consulting Inc., part of Accenture, Ottawa, ON K1P 1A4, Canada.
Patricia LloydCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Nader AlawarIBM Consulting, Bethesda, MD 20814, USA.
Timothy BurrellIBM Consulting, Bethesda, MD 20814, USA.ORCID 0000-0001-7973-7803
Jeff BeersIBM Consulting, Bethesda, MD 20814, USA.
Tainya C ClarkeCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Aaron Z HettingerCenter for Biostatistics, Informatics and Data Science, MedStar Health Research Institute, Hyattsville, MD 20782, USA.ORCID 0000-0003-0483-5788
Hui-Lee WongCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Azadeh ShoaibiCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 infections have contributed to substantial increases in hospitalizations. This study describes demographics, baseline clinical characteristics and treatments, and clinical outcomes among U.S. patients admitted to hospitals with COVID-19 during the prevaccine phase of the pandemic. A total of 20,446 hospitalized patients with a positive COVID-19 nucleic acid amplification test were identified from three large electronic health record databases during 5 February-30 November 2020 (Academic Health System:

Indexed as

COVID-19EHRepidemiologyhospitalizationtreatmentUnited States

Identifiers

PMID36986311
PMCPMC10056146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.